$TMDX 8-K SEC Filings

Filed On	Filing
10 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure Andover, Mass. – September 10, 2026 – TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), the global leader in portable warm perfusion for donor organs for transplantation, today announced the appointment of Fernando Araujo as Chief ...
04 Aug 2026	8-K: Results of Operations and Financial Condition
21 May 2026	8-K: Submission of Matters to a Vote of Security Holders
05 May 2026	8-K: Results of Operations and Financial Condition
27 Feb 2026	8-K: Results of Operations and Financial Condition
24 Feb 2026	8-K: Results of Operations and Financial Condition
04 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 Jan 2026	8-K: Entry into a Material Definitive Agreement; Other Events
29 Oct 2025	8-K: Results of Operations and Financial Condition
06 Oct 2025	8-K: Completion of Acquisition or Disposition of Assets
30 Jul 2025	8-K: Results of Operations and Financial Condition
23 May 2025	8-K: Submission of Matters to a Vote of Security Holders
08 May 2025	8-K: Results of Operations and Financial Condition
27 Feb 2025	8-K: Results of Operations and Financial Condition
21 Feb 2025	8-K: Completion of Acquisition or Disposition of Assets
14 Jan 2025	8-K: Completion of Acquisition or Disposition of Assets
09 Dec 2024	8-K: Completion of Acquisition or Disposition of Assets
02 Dec 2024	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
28 Oct 2024	8-K: Results of Operations and Financial Condition
11 Sep 2024	8-K: Completion of Acquisition or Disposition of Assets

Comments